Retina-targeted siRNA delivery via exosome-liposome hybrid vesicles for AMD treatment

Key Points

• Investigate a novel delivery system for siRNA targeting VEGF in neovascular age-related macular degeneration.
• Develop exosome-liposome hybrid vesicles for targeted siRNA delivery.
• Test the efficacy of the hybrid vesicles in delivering siRNA to retinal pigment epithelial cells in vitro.
• Evaluate the impact of siRNA on VEGF levels in retinal tissues.
• Hybrid vesicles significantly enhance siRNA delivery to retinal cells compared to conventional methods.
• Marked reduction in VEGF expression observed after treatment with the hybrid vesicles.
• Potential improvements in AMD treatment efficacy noted through targeted delivery mechanisms.